kidney transplant	is a	surgical procedure
kidney transplant	is performed for	end-stage renal disease
donor kidney	comes from	living donor
donor kidney	comes from	deceased donor
living donor	is a	donor type
deceased donor	is a	donor type
HLA matching	influences	graft survival
crossmatch	detects	donor-specific antibodies
panel reactive antibodies	indicates	sensitization
donor-specific antibodies	increase risk of	acute rejection
graft survival	improves with	good immunologic compatibility
immunosuppression	prevents	rejection
tacrolimus	is a	calcineurin inhibitor
cyclosporine	is a	calcineurin inhibitor
mycophenolate mofetil	is a	antiproliferative agent
prednisone	is a	corticosteroid
basiliximab	is a	induction agent
induction therapy	includes	basiliximab
induction therapy	includes	antithymocyte globulin
antithymocyte globulin	is a	polyclonal antibody
delayed graft function	occurs with	prolonged cold ischemia time
cold ischemia time	affects	graft function
ischemia-reperfusion injury	causes	early graft dysfunction
graft dysfunction	requires	dialysis
dialysis	is a	bridging therapy
post-transplant infection	is a	complication
immunosuppression	increases risk of	CMV infection
CMV infection	can cause	allograft injury
BK virus infection	can cause	nephropathy
infection	is a	major cause of readmission
nephrotoxicity	is a	side effect of calcineurin inhibitors
tacrolimus	can cause	nephrotoxicity
cyclosporine	can cause	nephrotoxicity
hypertension	is common after	kidney transplant
steroid-sparing regimens	aim for	reduced steroid exposure
new-onset diabetes after transplant	is a	complication
prednisone	increases risk of	new-onset diabetes after transplant
cardiovascular disease	is a	leading cause of mortality after transplant
obesity	increases risk of	post-transplant complications
obesity	reduces	graft survival
hyperlipidemia	is a	post-transplant complication
infection	leads to	readmission
CMV disease	is a	infection
BK virus nephropathy	is a	complication
crossmatch	should be	negative crossmatch
PRA	decreases after	transplantation
biopsy	confirms	rejection
acute rejection	requires	augmented immunosuppression
living donor kidney	improves	graft survival
deceased donor kidney	associated with	shorter graft survival
recipient age	affects	graft survival
donor age	affects	graft survival
donor kidney quality	impacts	graft survival
immune monitoring	informs	dosing
tacrolimus trough level	guides	dosing
cyclosporine trough level	guides	dosing
sirolimus	is a	mTOR inhibitor
sirolimus	can cause	hyperlipidemia
sirolimus	increases risk of	wound healing delay
graft biopsy	detects	rejection
protocol biopsy	detects	subclinical rejection
subclinical rejection	can cause	graft loss
alloantigen exposure	triggers	sensitization
prophylaxis	reduces	opportunistic infections
antiviral prophylaxis	reduces	CMV disease
protocol biopsy	evaluates	graft status
graft surveillance	includes	protocol biopsy
dialysis	is a	bridging modality
donor kidney quality	influences	graft function
recipient comorbidity	affects	transplant outcome
age at transplantation	predicts	graft survival
pre-transplant dialysis duration	correlates with	post-transplant outcomes
acute tubular necrosis	is a	post-transplant complication
vascular thrombosis	leads to	graft loss
wound infection	occurs after	transplantation
total ischemia time	determines	graft function
immunologic risk	stratifies	donor selection
HLA mismatch	affects	rate of rejection
ABO compatibility	required for	transplantation
donor-specific antibodies	cause	graft dysfunction
living donor evaluation	ensures	donor safety
preemptive transplant	avoids	dialysis
post-transplant vaccination	improves	recipient protection
influenza vaccination	recommended for	recipients
pneumococcal vaccination	recommended for	recipients
cancer risk	increases after	transplantation
post-transplant vaccination	is recommended for	recipients
urinary tract infection	is a	common post-transplant infection
wound healing	is a	postoperative concern
antibiotic prophylaxis	reduces	post-transplant infection risk
immunosuppression adherence	reduces	readmission risk
trough level monitoring	supports	dose optimization
pharmacogenomics	informs	tacrolimus dosing
allograft function	monitored by	creatinine trend
creatinine	reflects	allograft function
graft outcome	depends on	adherence to therapy
anesthesia	influences	perioperative risk
late acute rejection	occurs after	months post-transplant
graft thrombosis	causes	graft loss
long-term graft function	depends on	adherence to therapy
